title: [Meningococcosis in Tunisia. Apropos of 80 cases].
abstract: Meningococcosis are nowadays an health problem because their incidence rate (38 cases/100,000 people in 1986 in Mahdia region) and a high death rate (40%) due to fulminating forms. At the occasion of a prospective study during the first six months of 1987, the authors report the emergence of C serogroup (21%), the smallness of A serogroup (6.50%) and the predominance of B serogroup (68%). Improving level of living, good prophylaxy based on spiramycin, development of use of meningococcal vaccine are advisable means to control epidemic outbreaks.
authors.affiliation: Service de Pédiatrie, Hôpital Tahar-Sfar de Mahdia, Tunisie.
authors.forename: H
authors.initials: H
authors.lastname: Pousse
authors.forename: R
authors.initials: R
authors.lastname: Ben Mbarek
authors.forename: A
authors.initials: A
authors.lastname: Ayachi
authors.forename: H
authors.initials: H
authors.lastname: Soua
authors.forename: A
authors.initials: A
authors.lastname: Ayadi
authors.forename: H
authors.initials: H
authors.lastname: Braham
authors.forename: N
authors.initials: N
authors.lastname: Boujaffar
authors.forename: M T
authors.initials: MT
authors.lastname: Sfar
mesh_terms: D000293:Adolescent; D000328:Adult; D000667:Ampicillin / Q000627:therapeutic use; D001428:Bacterial Vaccines / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D008297:Male; D008585:Meningitis, Meningococcal / Q000453:epidemiology* / Q000382:microbiology / Q000517:prevention & control; D022401:Meningococcal Vaccines; D008875:Middle Aged; D009345:Neisseria meningitidis / Q000145:classification / Q000276:immunology; D011446:Prospective Studies; D012703:Serotyping; D014416:Tunisia / Q000453:epidemiology
chemical_list: D001428:Bacterial Vaccines; D022401:Meningococcal Vaccines; D000667:Ampicillin
vernacular_title: Les méningococcies en Tunisie. A propos de 80 cas.